Evaluation of CYT-108, A Recombinant Protease Inhibitor, for Treatment of Mild To Moderate Primary Osteoarthritis Of The Knee

Clinical trial NCT06263270 · COMPLETED

Trial details

NCT number: NCT06263270
Sponsor: Cytonics Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis

Start date: 2024-06-01
Primary completion: 2025-03-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.